Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleClinical Practice

Factor V Leiden with Deep Venous Thrombosis

Jeff Gardner
American Society for Clinical Laboratory Science January 2003, 16 (1) 6-9; DOI: https://doi.org/10.29074/ascls.16.1.6
Jeff Gardner
is a second year medical student at Wake Forest University School of Medicine, Winston-Salem NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jgardner@wfubmc.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Jeff Gardner⇑
    1. is a second year medical student at Wake Forest University School of Medicine, Winston-Salem NC
  1. Address for correspondence: Jeff Gardner, 828 Knollwood Street, Winston-Salem NC 27103. (336) 760-4405. jgardner{at}wfubmc.edu

Extract

Factor V Leiden (FVL) is an autosomal co-dominantly inherited Arg506→Gly substitution of the activated protein C cleavage site affecting 5% of the Caucasian population. FVL results in impaired anticoagulant function without procoagulant modification. Heterozygotes experience a seven-fold increase in thrombotic events, whereas homozygotes may incur a 50 to 100 fold increase. Even though patients are at increased risk for deep venous thrombi, they experience a smaller risk of pulmonary embolism compared to individuals affected by other coagulopathies.

PRESENTATION OF PATIENT A 45-year-old white female presented to an emergency room complaining of fever, cough, and left leg pain. Duplex ultra-sonography revealed a left greater saphenous thrombus with extension into the left common and femoral veins. The patient was discharged on oral warfarin. Two days later the patient returned to the hospital complaining of abdominal swelling, left upper quadrant pain, and epigastric tenderness. Additionally, the prothrombin time (PT) performed upon admission yielded an international normalized ratio (INR) of 1.0. A computed tomography (CT) scan revealed bilateral lung effusions without atelectasis and splenomegaly with multiple low density splenic masses. The patient stated that she experienced slight dyspnea upon exertion. The ventilation perfusion scan was not diagnostic for pulmonary embolus (PE). Upon interview, the patient revealed that she had two prior deep venous thrombi (DVT). Her first occurred at age 25 in her left leg after delivery of her second child. The second DVT occurred at age 43 in her right leg. Also of interest is the death of her daughter subsequent to a…

ABBREVIATIONS: APC = activated Protein C; APTT = activated partial thromboplastin time; CT - computed tomography; DVT = deep venous thrombosis; FV = factor V; FVL = Factor V Leiden; INR = international normalized ratio; LAC = lupus anticoagulant; PE = pulmonary embolus; PNH = paroxysmal nocturnal hemoglobinuria; PT = prothrombin time; RBC = red blood cell; SLE = systemic lupus rythematosus; V/Q ratio = ventilation/perfusion ratio.

    INDEX TERMS
  • Factor V Leiden
  • Protein C
  • thrombosis
  • © Copyright 2003 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 16 (1)
American Society for Clinical Laboratory Science
Vol. 16, Issue 1
Winter 2003
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factor V Leiden with Deep Venous Thrombosis
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Factor V Leiden with Deep Venous Thrombosis
Jeff Gardner
American Society for Clinical Laboratory Science Jan 2003, 16 (1) 6-9; DOI: 10.29074/ascls.16.1.6

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Factor V Leiden with Deep Venous Thrombosis
Jeff Gardner
American Society for Clinical Laboratory Science Jan 2003, 16 (1) 6-9; DOI: 10.29074/ascls.16.1.6
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Practice

  • Utility of Immunofixation as a Follow-up to Select Abnormal Serum Protein Electrophoresis Patterns and Suggestions for Clinical Correlation
  • Public Datasets: A Foundation to Artificial Intelligence in Health Care
  • Comparison of Laboratory Scientist and CellaVision DM9600 Classification of Reactive Lymphocytes
Show more Clinical Practice

Hemostasis

  • Hereditary Deficiencies of Antithrombin III, Protein S, and the Protein C Pathway in Jordanian Thrombosis Patients
Show more Hemostasis

Similar Articles

Keywords

  • factor V Leiden
  • Protein C
  • thrombosis

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire